Developers: | AliveCor |
Date of the premiere of the system: | November, 2017 |
2017: Beginning of sales
At the end of November, 2017 sales of the KardiaBand device turning the computerized Apple Watch watch into the electrocardiograph began. The accessory was created by AliveCor company.
Kardiaband is a miniature sensor of the size of a coin which fastens to Apple Watch thong (goes complete with Kardiaband). When the user leans a finger against electrodes, the wearable gadget removes a complete electrocardiogram (ECG) in only 30 seconds and instantly displays results on the smartphone screen. The ECG can be saved in mobile application and to send for interpretation to the attending physician.
Possibilities of Kardiaband are not limited to the ECG. Adaptation is capable to carry out broad diagnostics of violations of a rhythm of heart due to artificial intelligence, microelectrode technologies, cloud and mobile computing. So, the SmartRhythm function using mechanisms of machine learning allows the device to define an abnormal warm rhythm and fibrillation of auricles that, according to developers, is unavailable to any other accessory or the program for mobile devices.
The Reuters agency reported on November 30, 2017 that fibrillation of auricles is the most widespread cardiac arrhythmia which is among the main origins of a stroke and affects more than 30 million people around the world.
AliveCor claims that through Kardiaband hours of Apple Watch can precisely define aberrations in heartbeat of the person without participation of additional devices. The error in determination of deviations is estimated approximately at 2%.
Kardiaband became the first medical Apple Watch accessory, the approved Food and Drug Administration (FDA). The gadget costs $200 and requires a subscription to service of the company worth $100 a year.[1]